These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 31593353

  • 1. In vivo anti-inflammatory efficacy of the combined Bowman-Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybean.
    Sadeghalvad M, Mohammadi-Motlagh HR, Karaji AG, Mostafaie A.
    J Biochem Mol Toxicol; 2019 Dec; 33(12):e22406. PubMed ID: 31593353
    [Abstract] [Full Text] [Related]

  • 2. Bowman-Birk inhibitor and genistein among soy compounds that synergistically inhibit nitric oxide and prostaglandin E2 pathways in lipopolysaccharide-induced macrophages.
    Dia VP, Berhow MA, Gonzalez De Mejia E.
    J Agric Food Chem; 2008 Dec 24; 56(24):11707-17. PubMed ID: 19053380
    [Abstract] [Full Text] [Related]

  • 3. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
    Wan XS, Serota DG, Ware JH, Crowell JA, Kennedy AR.
    Nutr Cancer; 2002 Dec 24; 43(2):167-73. PubMed ID: 12588697
    [Abstract] [Full Text] [Related]

  • 4. Dietary supplementation of soybean kunitz trypsin inhibitor reduces lipopolysaccharide-induced lethality in mouse model.
    Kobayashi H, Yoshida R, Kanada Y, Fukuda Y, Yagyu T, Inagaki K, Kondo T, Kurita N, Suzuki M, Kanayama N, Terao T.
    Shock; 2005 May 24; 23(5):441-7. PubMed ID: 15834310
    [Abstract] [Full Text] [Related]

  • 5. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans.
    Maki PA, Paterson Y, Kennedy AR.
    Nutr Cancer; 1994 May 24; 22(2):185-93. PubMed ID: 14502847
    [Abstract] [Full Text] [Related]

  • 6. Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages.
    Li J, Ye L, Cook DR, Wang X, Liu J, Kolson DL, Persidsky Y, Ho WZ.
    J Neuroinflammation; 2011 Feb 15; 8():15. PubMed ID: 21324129
    [Abstract] [Full Text] [Related]

  • 7. Quantitative determination of active Bowman-Birk isoinhibitors, IBB1 and IBBD2, in commercial soymilks.
    Arques MC, Marín-Manzano MC, da Rocha LC, Hernandez-Ledesma B, Recio I, Clemente A.
    Food Chem; 2014 Jul 15; 155():24-30. PubMed ID: 24594149
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of Bowman-Birk protease inhibitor on autophagy in MDAMB231 breast cancer cell line.
    Kyani S, Akrami H, Mostafaei A, Akbari S, Salehi Z.
    J Cancer Res Ther; 2021 Jul 15; 17(2):504-509. PubMed ID: 34121699
    [Abstract] [Full Text] [Related]

  • 9. Probing the soybean Bowman-Birk inhibitor using recombinant antibody fragments.
    Muzard J, Fields C, O'Mahony JJ, Lee GU.
    J Agric Food Chem; 2012 Jun 20; 60(24):6164-72. PubMed ID: 22642722
    [Abstract] [Full Text] [Related]

  • 10. Isolation and characterization of soybean Bowman-Birk inhibitor from different sources.
    Gladysheva IP, Balabushevich NG, Moroz NA, Larionova NI.
    Biochemistry (Mosc); 2000 Feb 20; 65(2):198-203. PubMed ID: 10713547
    [Abstract] [Full Text] [Related]

  • 11. Contents and bioactivities of lunasin, bowman-birk inhibitor, and isoflavones in soybean seed.
    Park JH, Jeong HJ, de Lumen BO.
    J Agric Food Chem; 2005 Oct 05; 53(20):7686-90. PubMed ID: 16190617
    [Abstract] [Full Text] [Related]

  • 12. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR.
    Am J Clin Nutr; 1998 Dec 05; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [Abstract] [Full Text] [Related]

  • 13. Polylysine conjugates of Bowman-Birk protease inhibitor as targeted anti-carcinogenic agents.
    Persiani S, Yeung A, Shen WC, Kennedy AR.
    Carcinogenesis; 1991 Jun 05; 12(6):1149-52. PubMed ID: 2044199
    [Abstract] [Full Text] [Related]

  • 14. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
    Ekrami H, Kennedy AR, Witschi H, Shen WC.
    J Drug Target; 1993 Jun 05; 1(1):41-9. PubMed ID: 8069543
    [Abstract] [Full Text] [Related]

  • 15. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.
    Touil T, Ciric B, Ventura E, Shindler KS, Gran B, Rostami A.
    J Neurol Sci; 2008 Aug 15; 271(1-2):191-202. PubMed ID: 18544456
    [Abstract] [Full Text] [Related]

  • 16. Lunasin and Bowman-Birk protease inhibitor concentrations of protein extracts from enzyme-assisted aqueous extraction of soybeans.
    Leite Nobrega de Moura JM, Hernandez-Ledesma B, de Almeida NM, Hsieh CC, de Lumen BO, Johnson LA.
    J Agric Food Chem; 2011 Jul 13; 59(13):6940-6. PubMed ID: 21627325
    [Abstract] [Full Text] [Related]

  • 17. Fabrication of a Soybean Bowman-Birk Inhibitor (BBI) Nanodelivery Carrier To Improve Bioavailability of Curcumin.
    Liu C, Cheng F, Yang X.
    J Agric Food Chem; 2017 Mar 22; 65(11):2426-2434. PubMed ID: 28249113
    [Abstract] [Full Text] [Related]

  • 18. Protection against metastasis of radiation-induced thymic lymphosarcoma and weight loss in C57Bl/6NCr1BR mice by an autoclave-resistant factor present in soybeans.
    Evans SM, Van Winkle T, Szuhaj B, Michel KE, Kennedy AR.
    Radiat Res; 1992 Nov 22; 132(2):259-62. PubMed ID: 1438709
    [Abstract] [Full Text] [Related]

  • 19. The biochemical and functional food properties of the bowman-birk inhibitor.
    Losso JN.
    Crit Rev Food Sci Nutr; 2008 Jan 22; 48(1):94-118. PubMed ID: 18274967
    [Abstract] [Full Text] [Related]

  • 20. The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans.
    Birk Y.
    Int J Pept Protein Res; 1985 Feb 22; 25(2):113-31. PubMed ID: 3886572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.